205 related articles for article (PubMed ID: 8562412)
1. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders.
Li Y; Hetet G; Kiladjian JJ; Gardin C; Grandchamp B; Briere J
Br J Haematol; 1996 Jan; 92(1):60-6. PubMed ID: 8562412
[TBL] [Abstract][Full Text] [Related]
2. Clonality assays and megakaryocyte culture techniques in essential thrombocythemia.
Yan L; Elkassar N; Gardin C; Briere J
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():31-40. PubMed ID: 8951770
[TBL] [Abstract][Full Text] [Related]
3. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.
Taksin AL; Couedic JP; Dusanter-Fourt I; Massé A; Giraudier S; Katz A; Wendling F; Vainchenker W; Casadevall N; Debili N
Blood; 1999 Jan; 93(1):125-39. PubMed ID: 9864154
[TBL] [Abstract][Full Text] [Related]
4. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis.
Methia N; Louache F; Vainchenker W; Wendling F
Blood; 1993 Sep; 82(5):1395-401. PubMed ID: 7689867
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
[TBL] [Abstract][Full Text] [Related]
7. An agonist murine monoclonal antibody to the human c-Mpl receptor stimulates megakaryocytopoiesis.
Deng B; Banu N; Malloy B; Hass P; Wang JF; Cavacini L; Eaton D; Avraham H
Blood; 1998 Sep; 92(6):1981-8. PubMed ID: 9731056
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF.
Li Y; Hetet G; Maurer AM; Chait Y; Dhermy D; Briere J
Br J Haematol; 1994 Jul; 87(3):471-6. PubMed ID: 7993786
[TBL] [Abstract][Full Text] [Related]
9. Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders.
Duensing S; Duensing A; Meran JG; Kreft A; Büsche G; Ganser A; Georgii A
Mol Pathol; 1999 Jun; 52(3):146-50. PubMed ID: 10621836
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
[TBL] [Abstract][Full Text] [Related]
11. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
[TBL] [Abstract][Full Text] [Related]
12. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs.
Xie X; Chan RJ; Johnson SA; Starr M; McCarthy J; Kapur R; Yoder MC
Blood; 2003 Feb; 101(4):1329-35. PubMed ID: 12393382
[TBL] [Abstract][Full Text] [Related]
14. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.
Alexander WS; Roberts AW; Nicola NA; Li R; Metcalf D
Blood; 1996 Mar; 87(6):2162-70. PubMed ID: 8630375
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia.
Kuwana M; Okazaki Y; Kajihara M; Kaburaki J; Miyazaki H; Kawakami Y; Ikeda Y
Arthritis Rheum; 2002 Aug; 46(8):2148-59. PubMed ID: 12209520
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.
Elliot MA; Yoon SY; Kao P; Li CY; Tefferi A
Eur J Haematol; 2002 Mar; 68(3):175-9. PubMed ID: 12068799
[TBL] [Abstract][Full Text] [Related]
17. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets.
Debili N; Wendling F; Cosman D; Titeux M; Florindo C; Dusanter-Fourt I; Schooley K; Methia N; Charon M; Nador R
Blood; 1995 Jan; 85(2):391-401. PubMed ID: 7529061
[TBL] [Abstract][Full Text] [Related]
18. Role for C-MPL and its ligand thrombopoietin in early hematopoiesis.
Katayama N; Itoh R; Kato T; Sugawara T; Mahmud N; Ohishi K; Masuya M; Aoki M; Minami N; Miyazaki H; Shiku H
Leuk Lymphoma; 1997 Dec; 28(1-2):51-6. PubMed ID: 9498703
[TBL] [Abstract][Full Text] [Related]
19. Expression of thrombopoietin and thrombopoietin receptor MPL in human leukemia-lymphoma and solid tumor cell lines.
Graf G; Dehmel U; Drexler HG
Leuk Res; 1996 Oct; 20(10):831-8. PubMed ID: 8960108
[TBL] [Abstract][Full Text] [Related]
20. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome.
Letestu R; Vitrat N; Massé A; Le Couedic JP; Lazar V; Rameau P; Wendling F; Vuillier J; Boutard P; Plouvier E; Plasse M; Favier R; Vainchenker W; Debili N
Blood; 2000 Mar; 95(5):1633-41. PubMed ID: 10688818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
